Sagimet Biosciences (SGMT) Equity Ratio (2023 - 2024)
Sagimet Biosciences has reported Equity Ratio over the past 2 years, most recently at 0.98 for Q3 2024.
- Quarterly results put Equity Ratio at 0.98 for Q3 2024, up 2.7% from a year ago — trailing twelve months through Sep 2024 was 0.98 (up 2.7% YoY), and the annual figure for FY2023 was 0.94, changed.
- Equity Ratio for Q3 2024 was 0.98 at Sagimet Biosciences, up from 0.97 in the prior quarter.
- Over the last five years, Equity Ratio for SGMT hit a ceiling of 0.98 in Q1 2024 and a floor of 9.23 in Q2 2023.